Table 1.

Body composition was not altered by quercetin treatment in C3(1)/SV40Tag mice. All mice underwent a DEXA scan prior to treatment initiation(4 weeks), and at 12 and 16 weeks of age. No significant differences were detected between groups at each time point, P < 0.05 Values are means ± SEM

	C3(1)-Con	C3(1)-2%	C3(1)-0.2%	C3(1)-0.02%	FVB
4 weeks
Lean mass (g)	12.0 ± 0.4	12.1 ± 0.4	12.2 ± 0.4	12.1 ± 0.3	11.7 ± 0.2
Lean Mass (%)	88.6 ± 0.6	88.0 ± 0.5	87.1 ± 0.6	87.7 ± 0.6	87.6 ± 0.5
Body Fat (g)	1.6 ± 0.1	1.7 ± 0.1	1.9 ± 0.1	1.7 ± 0.1	1.7 ± 0.1
Body Fat (%)	11.5 ± 0.6	12.1 ± 0.5	13.1 ± 0.7	12.4 ± 0.6	12.6 ± 0.5
12 weeks
Lean mass (g)	14.2 ± 0.4	14.9 ± 0.2	14.2 ± 0.3	14.7 ± 0.2	14.6 ± 0.2
Lean Mass (%)	84.2 ± 0.9	84.5 ± 0.6	83.9 ± 0.8	84.1 ± 0.7	84.9 ± 0.7
Body Fat (g)	2.8 ± 0.2	2.8 ± 0.1	2.8 ± 0.2	2.9 ± 0.2	2.7 ± 0.2
Body Fat (%)	16.1 ± 0.9	15.9 ± 0.6	16.3 ± 0.8	16.2 ± 0.7	15.4 ± 0.7
16 weeks
Lean mass (g)	15.3 ± 0.4	15.4 ± 0.2	14.9 ± 0.3	15.2 ± 0.2	15.1 ± 0.3
Lean Mass (%)	84.3 ± 1.1	85.4 ± 0.6	83.8 ± 0.7	83.9 ± 0.8	83.4 ± 0.8
Body Fat (g)	3.0 ± 0.3	2.7 ± 0.1	3.0 ± 0.2	3.1 ± 0.2	3.1 ± 0.2
Body Fat (%)	15.9 ± 1.2	15.1 ± 0.6	16.6 ± 0.7	16.5 ± 0.8	16.9 ± 0.8